Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 22, 2024 09:15 ET | Source: Research and Markets

$230+ Bn Anti-Infectives Markets - Global Strategic Business Report to 2030: Telemedicine and Digital Health Platforms Drives Adoption, Rising Prevalence of Drug-Resistant Infections Spurs Innovation

Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Infectives - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Anti-Infectives...
January 30, 2024 06:44 ET | Source: Research and Markets

Metronidazole Market Forecast to 2032: Highlights Trends and the Competitive Landscape in CDI Treatment

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Metronidazole Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This insightful report provides...
January 29, 2024 12:38 ET | Source: Research and Markets

Vancomycin Drug Insights and Market Forecast to 2032 for Clostridium Difficile Infection Treatment in Key Global Regions

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Vancomycin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report presents an in-depth...
December 14, 2023 10:33 ET | Source: Research and Markets

REBYOTA (RBX2660) Drug Insight and Market Forecasts, 2032: Focus on United States, Germany, France, Italy, Spain United Kingdom, and Japan

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "REBYOTA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
December 13, 2023 04:13 ET | Source: Research and Markets

SER-109: A Potential First-in-Class Investigational Oral Microbiome Therapeutic Designed to Reduce the Recurrence of CDI - Drug Insights and Market Forecasts to 2032

Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "SER-109 Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
September 28, 2023 06:23 ET | Source: Research and Markets

Global Ear Infection Treatment Market 2023-2028: Innovations in Ear Infection Therapy - Silk-Based Solutions and Smart Earbuds Pave the Way

Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Ear Infection Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
February 08, 2023 13:18 ET | Source: Research and Markets

2022 Parainfluenza Virus Infection Pipeline Insights: Featuring AlloVir, Ansun Biopharma and Moderna Therapeutics

Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Parainfluenza Virus Infection - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
August 09, 2021 04:33 ET | Source: Research and Markets

Carbapenem-Resistant Enterobacteriaceae Infection Market Research Report 2021: Marketed Products, Emerging Therapies, Major Markets, Epidemiology

Dublin, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The "Carbapenem-Resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to...
July 06, 2021 04:33 ET | Source: Research and Markets

Global Respiratory Virus Infection Drugs Market (2020 to 2030) - Industry Analysis, Size, Share, Growth, Trends and Forecasts

Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Virus Infection Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030" report has been added to...
February 24, 2021 08:03 ET | Source: Research and Markets

United States HIV Infection Drug Market Report 2021-2026: Success Rate Associated with the Available Anti-retrovirals are Continuing to Expand at Historic Levels

Dublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report has been added to ResearchAndMarkets.com's offering. "US HIV...

Next Page keyboard_arrow_right